Life Sciences
Lazio is the second-largest hub in Italy and one of the most important in Europe for the pharmaceutical and life sciences industry. The region hosts major international players alongside a network of highly innovative small and medium-sized enterprises, closely connected to public research centers.
Elaborations on Lazio Innova data – Year 2025

8 Universities in Lazio with departments dedicated to biomedicine
8 IRCCS (Scientific Institutes for Research, Hospitalization, and Healthcare)*
26 Specialized research centers
10K Researchers
The Castel Romano Technopole is a key incubator for the life sciences sector, hosting 12 well-established startups. It is one of the leading Italian centers for applied research and benefits from strong ties with top international partners in health and life sciences. Companies such as Reithera, Tekis, and ISPRA are based here.
Production growth
In recent years, the pharmaceutical and biomedical sectors have seen production increases of 25% and 8%, respectively. Today, the pharmaceutical sector—with a growth rate of 24.1%—accounts for over 40% of Lazio’s foreign sales. The Bioscience Technology District (DTB), established in 2008, is a founding member of the National Life Sciences Technology Cluster (ALISEI).
Investments
Over the last five years, the region has recorded a significant increase in biotech investments, rising from 17% to 21%. The biotech revenue of Lazio’s 70 companies is close to €3 billion, representing 26% of the national total.
Specializations
Key areas of specialization include innovative pharmaceuticals, vaccines, biomedical manufacturing, development of inhibitors for cancer treatment, e-health, medical devices.
A strategic sector of Lazio’s economy
The regional biosciences production district is one of Lazio’s flagship sectors:
300 companies (including major multinationals and innovative SMEs)
22 K employees
€ 9 B in revenue
€ 8 B in exports
